Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Orthofix International (OFIX) to Acquire Spinal Kinetics
-
Orthofix Announces Agreement to Acquire Spinal Kinetics
-
Natera (NTRA) PT Raised to $16 at Canaccord Genuity
-
Voyager Therapeutics (VYGR) PT Lowered to $35 at Canaccord Genuity
-
Benefitfocus (BNFT) PT Lowered to $29 at Canaccord Genuity
-
DSW Inc. (DSW) PT Raised to $22 at Canaccord Genuity
-
MongoDB (MDB) PT Raised to $45 at Canaccord Genuity; 'Very good across the board'
-
Sientra (SIEN) PT Lowered to $18 at Canaccord Genuity
-
Senseonics Holdings (SENS) PT Lowered to $4 at Canaccord Genuity
-
ICV Partners Announces Acquisition of Outpatient Imaging Affiliates
-
Canaccord Genuity Upgrades Randgold Resources Ltd. (GOLD) to Buy
-
BLOK Technologies Announces $3 Million Brokered Private Placement Co-Led by Canaccord Genuity and Gravitas Securities
-
Insulet Corporation (PODD) PT Raised to $90 at Canaccord Genuity
-
ReWalk Robotics Ltd. (RWLK) PT Lowered to $2 at Canaccord Genuity
-
BioXcel Therapeutics Announces Closing of Initial Public Offering
-
BioXcel Therapeutics Announces Closing of Initial Public Offering
-
iRhythm Technologies (IRTC) PT Raised to $80 at Canaccord Genuity
-
Karyopharm Therapeutics (KPTI) PT Raised to $22 at Canaccord Genuity
-
Dick's Sporting Goods (DKS) PT Lowered to $33 at Canaccord Genuity
-
MYR Group (MYRG) PT Raised to $42 at Canaccord Genuity
-
Upland Software (UPLD) PT Raised to $32 at Canaccord Genuity
-
Genomic Health Inc. (GHDX) PT Lowered to $40 at Canaccord Genuity
-
CryoLife (CRY) PT Raised to $28 at Canaccord Genuity
-
Reis (REIS) to Explore Strategic Alternatives
-
Reis, Inc. to Explore Strategic Alternatives
-
Reis, Inc. to Explore Strategic Alternatives
-
BioXcel Therapeutics Announces Pricing of Initial Public Offering
-
Tyme Technologies Announces Closing of Public Offering of Common Stock
-
Tyme Technologies Announces Closing of Public Offering of Common Stock
-
MeetMe (MEET) PT Lowered to $3 at Canaccord Genuity; 'Solid Q4 as video monetization ramps'
-
Okta, Inc (OKTA) PT Raised to $36 at Canaccord Genuity; 'Excellent growth, high valuation'
-
Mukuba Announces Closing of Private Placement by FogChain, Inc.
-
T2 Biosystems, Inc (TTOO) PT Raised to $7 at Canaccord Genuity Citing Model Roll Forward to 2020 Estimates
-
Dividend Select 15 Corp. Announces Successful Overnight Offering
-
Ameresco (AMRC) PT Raised to $11.50 at Canaccord Genuity; 'Market (and model) have momentum'
-
Canaccord Genuity Downgrades Coeur d'Alene Mines (CDE) to Hold
-
Horizonte Minerals Plc: Q1 2018 Operational Update
-
Autodesk (ADSK) PT Raised to $150 at Canaccord Genuity
-
DSW Inc. (DSW) PT Lowered to $20 at Canaccord Genuity
-
Dividend Select 15 Corp. Announces Overnight Offering
-
Canaccord Genuity Expands North American Debt Finance & Restructuring Team
-
Obalon Therapeutics (OBLN) PT Lowered to $10 at Canaccord Genuity
-
Medicrea to Participate in the Canaccord Genuity Musculoskeletal Conference and Present Clinical Results at AAOS 2018
-
Foot Locker (FL) PT Lowered to $66 at Canaccord Genuity
-
CalAmp Corp. (CAMP) PT Raised to $29 at Canaccord Genuity
-
Dynatronics to Participate in 2018 Canaccord Musculoskeletal Conference in New Orleans, Louisiana
-
Canaccord Downgrades Quarterhill Inc. (QTRH) to Spec. Buy, 'Choppy results; awaiting first moves of rebuilt management team'
-
Canaccord Genuity Downgrades Versartis (VSAR) to Hold
-
Nektar Therapeutics (NKTR) PT Raised to $94 at Canaccord Genuity
-
Tyme Inc. (TYME) Prices 9M Share Offering at $2.25/Sh


